• Microbix Biosystems Inc., of Toronto, and Zydus Cadila, of Ahmedabad, India, signed a letter of intent to market thrombolytic drug Urokinase in North American markets. Microbix acquired rights to the drug in 2008. Financial terms were not disclosed.